MILLER; Guy M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MILLER; Guy M..The latest application filed is for "methods and compositions for treatment of inflammation and oxidative stress".

Company Profile

9.18.62

MILLER; Guy M. - Monte Sereno CA
- unknown
Miller; Guy M. - Carmel CA
Miller; Guy M. - San Jose CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Treatment Of Inflammation And Oxidative Stress App 20220257533 - MILLER; Guy M. ; et al.	2022-08-18
Treatment Of Leigh Syndrome And Leigh-like Syndrome With Tocotrienol Quinones App 20220133648 - Jankowski; Orion D. ; et al.	2022-05-05
Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers App 20220055975 - Miller; Guy M. ; et al.	2022-02-24
Treatment Of Oxidative Stress Disorders Including Contrast Nephropathy, Radiation Damage And Disruptions In The Function Of Red Cells App 20210322337 - MILLER; Guy M.	2021-10-21
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 11,021,424 - Miller , et al. June 1, 2	2021-06-01
Treatment Of Methylmalonic Aciduria, Isovaleric Aciduria, And Other Organic Acidurias With Tocotrienol Quinones App 20210145769 - MILLER; Guy M. ; et al.	2021-05-20
Treatment Of Pervasive Developmental Disorders With Redox-active Therapeutics App 20210128494 - MILLER; Guy M. ; et al.	2021-05-06
Treatment of pervasive developmental disorders with redox-active therapeutics Grant 10,736,857 - Miller , et al. A	2020-08-11
Methods And Compositions For Treatment Of Inflammation And Oxidative Stress App 20200121618 - MILLER; Guy M. ; et al.	2020-04-23
Treatment Of Leigh Syndrome And Leigh-like Syndrome With Tocotrienol Quinones App 20190216749 - Miller; Guy M. ; et al.	2019-07-18
Treatment Of Pervasive Developmental Disorders With Redox-active Therapeutics App 20190083419 - Miller; Guy M. ; et al.	2019-03-21
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones Grant 10,195,161 - Miller Fe	2019-02-05
Methods and systems for defending cyber attack in real-time Grant 10185832 -	2019-01-22
Modified antipodal vivaldi antenna with elliptical loading Grant 10186783 -	2019-01-22
Methods For The Prevention And Treatment Of Cerebral Ischemia App 20180344667 - Miller; Guy M. ; et al.	2018-12-06
Vitamin E Compositions And Methods Of Use Therefor App 20180333389 - Miller; Guy M.	2018-11-22
Treatment Of Oxidative Stress Disorders Including Contrast Nephropathy, Radiation Damage And Disruptions In The Function Of Red Cells App 20180303767 - MILLER; Guy M.	2018-10-25
Treatment Of Methylmalonic Aciduria, Isovaleric Aciduria, And Other Organic Acidurias With Tocotrienol Quinones App 20180303770 - MILLER; Guy M. ; et al.	2018-10-25
Treatment of pervasive developmental disorders with redox-active therapeutics Grant 10,105,325 - Miller , et al. October 23, 2	2018-10-23
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells Grant 10,039,722 - Miller August 7, 2	2018-08-07
Treatment Of Hearing And Balance Impairments With Redox-active Therapeutics App 20180200248 - Miller; Guy M.	2018-07-19
Formulations Of Tocotrienol Quinones For The Treatment Of Ophthalmic Diseases App 20180116978 - Miller; Guy M. ; et al.	2018-05-03
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,932,286 - Miller , et al. April 3, 2	2018-04-03
Formulations Of Quinones For The Treatment Of Ophthalmic Diseases App 20170354618 - Miller; Guy M.	2017-12-14
Treatment Of Leigh Syndrome And Leigh-like Syndrome With Tocotrienol Quinones App 20170246124 - MILLER; Guy M. ; et al.	2017-08-31
Treatment Of Pervasive Developmental Disorders With Redox-active Therapeutics App 20170157065 - Miller; Guy M.	2017-06-08
Treatment Of Leber's Hereditary Optic Neuropathy And Dominant Optic Atrophy With Tocotrienol Quinones App 20170119695 - Miller; Guy M.	2017-05-04
Methods For The Prevention And Treatment Of Cerebral Ischemia App 20170007553 - Miller; Guy M. ; et al.	2017-01-12
Treatment Of Mitochondrial Diseases App 20160324823 - WALKINSHAW; Gail ; et al.	2016-11-10
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,447,006 - Miller , et al. September 20, 2	2016-09-20
Side-chain Variants Of Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers App 20160244392 - Miller; Guy M. ; et al.	2016-08-25
Treatment of pervasive developmental disorders with redox-active therapeutics Grant 9,399,612 - Miller July 26, 2	2016-07-26
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones Grant 9,370,496 - Miller June 21, 2	2016-06-21
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 9,278,085 - Miller , et al. March 8, 2	2016-03-08
Treatment Of Pervasive Developmental Disorders With Redox-active Therapeutics App 20150239818 - MILLER; Guy M. ; et al.	2015-08-27
Quinone Derivatives For Use In The Modulation Of Redox Status Of Individuals App 20150216820 - Miller; Guy M. ; et al.	2015-08-06
Treatment of pervasive developmental disorders with redox-active therapeutics Grant 8,969,420 - Miller , et al. March 3, 2	2015-03-03
Treatment Of Methylmalonic Aciduria, Isovaleric Aciduria, And Other Organic Acidurias With Tocotrienol Quinones App 20150057363 - Miller; Guy M. ; et al.	2015-02-26
Treatment Of Leigh Syndrome And Leigh-like Syndrome With Tocotrienol Quinones App 20140343166 - MILLER; Guy M. ; et al.	2014-11-20
Treatment Of Hearing And Balance Impairments With Redox-active Therapeutics App 20140249160 - MILLER; Guy M.	2014-09-04
Treatment Of Pervasive Developmental Disorders With Redox-active Therapeutics App 20140206772 - Miller; Guy M. ; et al.	2014-07-24
Treatment of pervasive developmental disorders with redox-active therapeutics Grant 8,653,144 - Miller , et al. February 18, 2	2014-02-18
Treatment Of Leber's Hereditary Optic Neuropathy And Dominant Optic Atrophy With Tocotrienol Quinones App 20140039065 - MILLER; Guy M.	2014-02-06
Formulations Of Tocotrienol Quinones For The Treatment Of Ophthalmic Diseases App 20140031433 - MILLER; Guy M. ; et al.	2014-01-30
Treatment Of Mitochondrial Diseases With Vitamin K App 20140031432 - Jankowski; Orion D. ; et al.	2014-01-30
Treatment Of Mitochondrial Diseases With Naphthoquinones App 20130345312 - Jankowski; Orion D. ; et al.	2013-12-26
Treatment Of Mitochondrial Diseases App 20130267538 - WALKINSHAW; Gail ; et al.	2013-10-10
Formulations Of Quinones For The Treatment Of Ophthalmic Diseases App 20130109759 - Miller; Guy M.	2013-05-02
Treatment Of Pervasive Developmental Disorders With Redox-active Therapeutics App 20130053450 - MILLER; Guy M. ; et al.	2013-02-28
Methods For Improving Blood Glucose Control App 20120295985 - Miller; Guy M. ; et al.	2012-11-22
Treatment of pervasive developmental disorders with redox-active therapeutics Grant 8,314,153 - Miller , et al. November 20, 2	2012-11-20
Topical, Periocular, Or Intraocular Use Of Tocotrienols For The Treatment Of Ophthalmic Diseases App 20120136048 - Miller; Guy M. ; et al.	2012-05-31
Treatment Of Pervasive Developmental Disorders With Tocotrienols Or Tocotrienol Enriched Extracts App 20120122969 - Miller; Guy M.	2012-05-17
Treatment Of Oxidative Stress Disorders Including Contrast Nephropathy, Radiation Damage And Disruptions In The Function Of Red Cells App 20110269776 - Miller; Guy M.	2011-11-03
Methods For The Prevention And Treatment Of Cerebral Ischemia App 20110207828 - Miller; Guy M. ; et al.	2011-08-25
Treatment Of Leigh Syndrome And Leigh-like Syndrome With Tocotrienol Quinones App 20110172312 - MILLER; Guy M. ; et al.	2011-07-14
Treatment Of Hearing And Balance Impairments Using Compounds Having Erythropoietin Activity App 20110142834 - Miller; Guy M.	2011-06-16
Treatment Of Hearing And Balance Impairments With Redox-active Therapeutics App 20110046156 - Miller; Guy M.	2011-02-24
Formulations Of Tocotrienol Quinones For The Treatment Of Ophthalmic Diseases App 20100273892 - MILLER; Guy M. ; et al.	2010-10-28
Treatment Of Leber's Hereditary Optic Neuropathy And Dominant Optic Atrophy With Tocotrienol Quinones App 20100273894 - MILLER; Guy M.	2010-10-28
Redox-active Therapeutics For Treatment Of Mitochondrial Diseases And Other Conditions And Modulation Of Energy Biomarkers App 20100222436 - Miller; Guy M. ; et al.	2010-09-02
Treatment Of Pervasive Developmental Disorders With Redox-active Therapeutics App 20100063161 - MILLER; Guy M. ; et al.	2010-03-11
Treatment Of Respiratory Chain Disorders Using Compounds Having Erythropoietin Or Thrombopoietin Activity App 20100056429 - Miller; Guy M. ; et al.	2010-03-04
Naphthoquinone Compositions With Anti-aging, Anti-inflammatory And Skin Even-toning Properties App 20100029784 - Hinman; Andrew W. ; et al.	2010-02-04
HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS App 20100029706 - Miller; Guy M. ; et al.	2010-02-04
Dermatological Compositions With Anti-aging And Skin Even-toning Properties App 20100010100 - Hinman; Andrew W. ; et al.	2010-01-14
Treatment Of Mitochondrial Diseases With An Erythropoietin Mimetic App 20090291092 - MILLER; Guy M. ; et al.	2009-11-26
Identifying Therapeutic Compounds Based On Their Physical-chemical Properties App 20090162890 - GILAT; Sylvain ; et al.	2009-06-25
Identifying Therapeutic Compounds Based On Their Physical-chemical Properties App 20090163529 - GILAT; Sylvain ; et al.	2009-06-25
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Grant 7,432,305 - Miller , et al. October 7, 2	2008-10-07
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers App 20070225261 - Miller; Guy M. ; et al.	2007-09-27
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers App 20070072943 - Miller; Guy M. ; et al.	2007-03-29
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers App 20060281809 - Miller; Guy M. ; et al.	2006-12-14
Compositions and methods for the prevention and treatment of cerebral ischemia App 20040152764 - Miller, Guy M. ; et al.	2004-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.